Plectix Biosystems Frequently Asked Questions (FAQ)
Where is Plectix Biosystems's headquarters?
Plectix Biosystems's headquarters is located at 20 Holland Street, Suite 400, Somerville.
What is Plectix Biosystems's latest funding round?
Plectix Biosystems's latest funding round is Other Investors.
Who are the investors of Plectix Biosystems?
Investors of Plectix Biosystems include Sevin Rosen Funds.
Who are Plectix Biosystems's competitors?
Competitors of Plectix Biosystems include Knopp Biosciences, Global Integrity, Primorigen Biosciences, Guava Technologies, California Stem Cell and 11 more.
Compare Plectix Biosystems to Competitors
Global Integrity generates, synthesizes, and disseminates information on governance and corruption trends around the world.
IntelCell markets a product platform engineered to modernize research techniques for cell and tissue growth. The company's first product, Cell Drive, replaces traditional cell culture equipment by providing an unprecedented level of usability and sophistication for the user. For scientists whose research depends upon live cell culture, Cell Drive aims to offer a compact, precision, cell growth system that increases experimental control, aims to improve sterility, aims to provide digitization of data and methods, and aims to reduce human error and labor costs.
Areta International was founded, with totally private financial support, by Dr. Maria Luisa Nolli in autumn 1999 as a spin-off of cell biology Laboratories of Lepetit Research Center, part of multinational companies, where she had a twenty years experience as scientist and team leader. nnThe company was born to cover the gap existing between the excellent basic research and the poor development of discoveries, with a view of helping customers to transform research projects in new potential biodrugs. nn nn
BioSilta, founded in 2007 in Oulu, Finland, utilizes its unique, proprietary EnBase technology platform to develop innovative, reagent-based EnPresso growth systems. When compared to conventional growth media, these growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
Montana Molecular was founded in 2004 to develop and commercialize fluorescent proteins (FPs) for live cell imaging applications. The technology that underlies this effort was originally conceived by Thomas Hughes at Yale University. Dr. Hughes is now the head of the Department of Cell Biology and Neuroscience at Montana State University. The Company has used this technology to develop several new read-outs for pharmaceutical and biotechnology applications, including genetically encoded fluorescent markers, a system for detecting protein-protein interaction, and biosensors for cell-based high throughput drug discovery.
Cardiovasc is a cardiovascular research group that explores the cellular mechanisms responsible for major cardiovascular and metabolic diseases and to identify new cellular targets for drug therapys to help protect the cardiovascular system.